[HTML][HTML] A pharmacological chaperone therapy for acute intermittent porphyria
HJ Bustad, K Toska, C Schmitt, M Vorland, L Skjærven… - Molecular Therapy, 2020 - cell.com
Mutations in hydroxymethylbilane synthase (HMBS) cause acute intermittent porphyria (AIP),
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
[HTML][HTML] A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria
HJ Bustad, K Toska, C Schmitt, M Vorland, L Skjærven… - Molecular Therapy, 2020 - Elsevier
Mutations in hydroxymethylbilane synthase (HMBS) cause acute intermittent porphyria (AIP),
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria
HJ Bustad, K Toska, C Schmitt, M Vorland, L Skjærven… - 2019 - bora.uib.no
Mutations in hydroxymethylbilane synthase (HMBS) cause acute intermittent porphyria (AIP),
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
[PDF][PDF] A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria
HJ Bustad, K Toska, C Schmitt, M Vorland… - Molecular …, 2020 - researchgate.net
Mutations in hydroxymethylbilane synthase (HMBS) cause acute intermittent porphyria (AIP),
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
[引用][C] A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria
H Bustad, K Toska, C Schmitt, M Vorland… - Molecular …, 2019 - hal.science
A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria - Archive ouverte HAL
Accéder directement au contenu Documentation FR Français (FR) Anglais (EN) Se connecter …
Accéder directement au contenu Documentation FR Français (FR) Anglais (EN) Se connecter …
A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria.
HJ Bustad, K Toska, C Schmitt, M Vorland… - … Therapy: the Journal …, 2019 - europepmc.org
Mutations in hydroxymethylbilane synthase (HMBS) cause acute intermittent porphyria (AIP),
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria
HJ Bustad, K Toska, C Schmitt… - … therapy: the journal …, 2020 - pubmed.ncbi.nlm.nih.gov
Mutations in hydroxymethylbilane synthase (HMBS) cause acute intermittent porphyria (AIP),
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
[HTML][HTML] A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria
HJ Bustad, K Toska, C Schmitt, M Vorland… - Molecular …, 2020 - ncbi.nlm.nih.gov
Mutations in hydroxymethylbilane synthase (HMBS) cause acute intermittent porphyria (AIP),
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
[PDF][PDF] A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria
HJ Bustad, K Toska, C Schmitt, M Vorland… - Molecular …, 2020 - scienceopen.com
Mutations in hydroxymethylbilane synthase (HMBS) cause acute intermittent porphyria (AIP),
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …
an autosomal dominant disease where typically only one HMBS allele is mutated. In AIP, the …